Blue Owl stock is gaining Wall Street's attention. Read what investors should know about the challenges facing this company.
The philosopher and social theorist, Jürgen Habermas, who has died at the age of 96, towered over the intellectual life of ...
An exclusive interview with Dr. Shantanu Agrawal—plus, updates on H-1B visas, Nvidia and a cross-market health system deal.
Biologist and author Paul Ehrlich, the most influential Chicken Little of the last century, died at the age of 93 this week. His 1968 book, “The Population Bomb,” launched decades of institutional ...
Mirror’ displays a deliberately restricted vocabulary while his ‘Rite of Spring’ finds real and virtual dancers going through ...
Petrochemical giant LyondellBasell Industries (NYSE: LYB) has surged 73.7% year-to-date to $75.20 as of March 18, 2026. For retirement investors who watched from the sidelines, one question is ...
Analysts and technical indicators point to a convergence of bullish technical signals and structural fundamental catalysts ...
As more companies and workers adopt AI for professional and personal uses, Edward Jones CEO Penny Pennington sits down with Yahoo Finance Executive Editor Brian Sozzi to speak about how clients may ...
Perhaps the most remarkable thing is not that Paul Ehrlich turned out to be so wildly wrong, writes conservative columnist Jonah Goldberg, but that he was so obviously wrong from the beginning.
This week saw new funding for a GPS alternative, a homegrown legal AI system, and a startup challenging an all-too-common health condition.
GIP obesity drug enters Phase 3 with strong cash runway, but rising competition and trial risk. Click for this VKTX update.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results